|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07D 401/14 | |
| C07D 213/82 | |||
| C07D 213/81 | |||
| C07D 401/06 | |||
| C07D 237/24 | |||
| C07D 261/18 | |||
| C07D 403/06 |
| (11) | Number of the document | 2846803 |
| (13) | Kind of document | T |
| (96) | European patent application number | 13722661.9 |
| Date of filing the European patent application | 2013-05-08 | |
| (97) | Date of publication of the European application | 2015-03-18 |
| (45) | Date of publication and mention of the grant of the patent | 2017-06-21 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2013/040117 |
| Date | 2013-05-08 |
| (87) | Number | WO 2013/169889 |
| Date | 2013-11-14 |
| (30) | Number | Date | Country code |
| 201261644318 P | 2012-05-08 | US | |
| 201261644411 P | 2012-05-08 | US | |
| 201261645935 P | 2012-05-11 | US | |
| 201361801544 P | 2013-03-15 | US |
| (72) |
PUTMAN, David, US
DASSE, Olivier, US
|
| (73) |
Alpharmagen, LLC,
280 Utah Avenue, Suite 275, South San Francisco, CA 94080,
US
|
| (54) | ALPHA 7 NICOTINIC ACETYLCHOLINE RECEPTOR ALLOSTERIC MODULATORS, THEIR DERIVATIVES AND USES THEREOF |
| ALPHA 7 NICOTINIC ACETYLCHOLINE RECEPTOR ALLOSTERIC MODULATORS, THEIR DERIVATIVES AND USES THEREOF |